B.C. pharmaceutical company’s stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Saanich-based pharmaceutical company, Aurinia Pharmaceuticals, saw share values soar on Thursday after success with clinical trials for a new lupus drug.

On Dec. 4, the company announced that results from the AURORA Phase 3 drug trials for voclosporin had been successful in treating kidney inflammation in patients with lupus nephritis – an autoimmune disease.

Aurinia’s chief medical officer Neil Solomons explained that patients with lupus can experience “irreversible kidney damage” that can lead to kidney failure and death.

READ ALSO: Saanich biotech company secures $52M US for global drug study

The study included 357 patients from around the world with lupus and the results showed that participants using voclosporin experienced a “renal response rate” of 40.8 per cent while just 22.5 per cent of participants in the control group – those who didn’t receive the drug – saw improvements.

Data also indicated that the group taking voclosporin saw no more adverse events than the group receiving standard lupus treatment, noted Brad Rovin, chief of the nephrology division at the Ohio State University Wexner Medical Centre.

Following the announcement of the drug’s successful Phase 3 trial, the company’s share price exploded on Thursday, rising from Wednesday’s close of $11.13 per share to touch a 52-week high of $23.04 before closing at $19.75. Its shares have risen from a 52-week low of $4.70 to close Friday at $20.48 – a gain of 336 per cent, driving the company’s market cap to $1.93 billion.

READ ALSO: Mental health call temporarily shuts down Trans Canada Highway in View Royal

Lupus has historically been difficult to treat and new treatment options were needed, said Stevan Gibson, president and CEO of the Lupus Foundation of America. Voclosporin is the first effective therapeutic treatment option and the successful trial marks a step forward in treating the potentially deadly disease, he noted.

Chief executive Peter Greenleaf noted that staff were “thrilled with the outcomes” of the trial and that the drug’s success is significant for people living with lupus – close to 3 million people worldwide. The company is planning to put the drug on the market as early as 2021, but first it must pass though the U.S. Food and Drug Administration (FDA) process. The drug was given a fast track by the FDA in 2016 and the company plans to submit to the FDA in early 2020.

With files from Paul Bucci.


@devonscarlett
Like us on Facebook and follow us on Twitter.

devon.bidal@saanichnews.com

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Charges discontinued in 2017 shooting death of Penticton man

The manslaughter charge against Sylvain Demers has been stayed by Crown

Fire crews respond to ‘false malicious’ fire alarm at Penticton business

The Penticton Fire Department was called to a structure fire that turned out to be a false alarm

“Who” dunnit? Penticton RCMP seek midnight masked bandit

If you recognize this culprit and give a hoot, call Penticton RCMP

Penticton man arrested, charged for local drug trafficking operation

41-year-old Ryan Chaffey of Penticton was arrested at a suite on the 1000 block of Westminster Ave.

Penticton curlers reflect on B.C. Winter Games

If they could do it again, they would. A group of junior… Continue reading

RCMP ask court about disposal of evidence in Robert Pickton case

Pickton was sentenced to life with no chance of parole for 25 years for the murders of six women

Wet’suwet’en hereditary chiefs optimistic ahead of talks with feds, province

Discussions with provincial and federal governments expected to start later today

‘The project is proceeding’: Horgan resolute in support of northern B.C. pipeline

B.C. premier speaks as talks scheduled with Wet’suwet’en hereditary chiefs

BREAKING: Kelowna RCMP to further investigate 12 sexual assault cases, create sexual assault unit

Recommendations come five months after it was revealed 40% of sexual assaults were deemed ‘unfounded’

Businesses nominated for excellence awards

Upcoming awards ceremony has 67 nominees in 12 categories

Explicit Greta sticker linked to Alberta company draws outrage

The sticker includes the logo of Red Deer-based X-Site Energy Services

Share Now, formerly Car2Go, leaves Canada with valuable data in changing market: expert

Vancouver was its largest market in North America, with more than 300,000 customers

EDITORIAL: Standards of care

The decision to appoint an administrator at Summerland Seniors Village raises important questions

Off-duty RCMP officer helps catch Cache Creek car thief

‘This is just one example of how we are always ready to respond to emergencies’

Most Read